Drug intelligence / Profile preview

Livocumin

Development stage: Unknown
Lead developer: Anglo-French Drugs & Industries
Modality: Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration: Oral

Overview

Livocumin is an Ayurvedic liver supplement developed and manufactured by Anglo-French Drugs & Industries. It is formulated as an oral tablet containing a blend of ten natural herbs, including curcumin (turmeric), chitraka (*Plumbago zeylanica*), katuka (*Picrorhiza kurroa*), maricha (*Piper nigrum*), ardraka (*Zingiber officinale*), and amalaki (*Emblica officinalis*). Livocumin exhibits hepatoprotective, antioxidant, and anti-inflammatory properties, helping to cleanse, detoxify, and strengthen the liver. It is used to support healthy liver function and aid in the management of liver disorders such as non-alcoholic fatty liver disease (NAFLD), alcoholic fatty liver disease, jaundice, infective hepatitis, gallstones, and indigestion.

Brand names: Livocumin
Other names: Livocumin Livo Tonic

Targets

ALOX12 (Arachidonate 12-lipoxygenase, 12S type)MMP3 (Matrix metalloproteinase-3)GSK3 (Glycogen synthase kinase 3 beta)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on Livocumin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Livocumin.

Explore the full profile